Literature DB >> 22076764

Synthesis of novel 4-(1H-benzimidazol-2-yl)benzene-1,3-diols and their cytotoxic activity against human cancer cell lines.

Monika M Karpińka1, Joanna Matysiak, Andrzej Niewiadomy.   

Abstract

One-pot synthesis of new biologically active 4-(1H-benzimidazol-2-yl)benzene-l,3-diols has been developed. The compounds were prepared by the reaction of aryl-modified sulfinylbis[(2,4-dihydroxyphenyl)methanethione]s with benzene-l,2-diamines. Their structures were identified using elemental, IR, (1)H-NMR, and mass spectra analyses. The developed method offers short reaction times, relatively large-scale synthesis, easy and quick isolation of the products, and good yields. The cytotoxicity in vitro against the 4 human cancer cell lines: SW707 (rectal), HCV29T (bladder), A549 (lung), and T47D (breast) was determined. The antiproliferative properties of some compounds studies were stronger than those of cisplatin, which was used as a comparator drug.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22076764     DOI: 10.1007/s12272-011-1008-0

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  2 in total

1.  Crystal structures of pure 3-(4-bromo-2-chloro-phen-yl)-1-(pyridin-4-yl)benzo[4,5]imidazo[1,2-d][1,2,4]triazin-4(3H)-one and contaminated with 3-(4-bromo-phen-yl)-1-(pyridin-4-yl)benzo[4,5]imidazo[1,2-d][1,2,4]triazin-4(3H)-one.

Authors:  Kanan Wahedy; Bassam Abu Thaher; Dieter Schollmeyer; Ihab Almasri; Rami Morjan; Basem Qeshta; Hans-Peter Deigner
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2017-08-15

2.  Biological Evaluation, Molecular Docking, and SAR Studies of Novel 2-(2,4-Dihydroxyphenyl)-1H- Benzimidazole Analogues.

Authors:  Joanna Matysiak; Alicja Skrzypek; Monika Karpińska; Kamila Czarnecka; Paweł Szymański; Marek Bajda; Andrzej Niewiadomy
Journal:  Biomolecules       Date:  2019-12-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.